Comprehensive Financial Management LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1799802 Los Gatos, CA

Position in DNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$108,231

-$38,490 QoQ

Shares Held

17,656

0.0% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Comprehensive Financial Management LLC holds $12,795,609 across 4 Biotechnology names. DNA ranks #4 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NAUT	Nautilus Biotechnology, Inc.	2,207,619	$8,565,561
2	RXRX	Recursion Pharmaceuticals, Inc.	941,895	$2,891,617
3	EIKN	Eikon Therapeutics, Inc.	116,276	$1,230,200
4	DNA	Ginkgo Bioworks Holdings, Inc. This page	17,656	$108,231

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$108,231	17,656	0.0%	Shares	Sole	2026-05-15
2025-12-31	$146,721	17,656	0.0%	Shares	Sole	2026-02-17
2025-09-30	$257,424	17,656	0.0%	Shares	Sole	2025-11-14
2025-06-30	$198,630	17,656	0.0%	Shares	Sole	2025-08-12
2025-03-31	$100,639	17,656	0.0%	Shares	Sole	2025-05-15
2024-12-31	$173,381	17,656	0.0%	Shares	Sole	2025-02-14
2024-09-30	$143,896	17,656	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.